← Eichor
Study identifier: NCT06862206 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

Condition: Chronic Obstructive Pulmonary Disease  ·  Sponsor: AstraZeneca

PhaseN/A
Planned participants1000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

The objective of this study is to collect empirical data that elucidates the clinical profile and therapeutic efficacy of benralizumab among the patients aged 12 years and above, with severe eosinophilic asthma. The study will focus on the early treatment response, treatment outcomes and the change in asthma control of benralizumab therapy in a real-world setting in China. This study will also describe the physician-reported reasons for discontinuation and switching of benralizumab therapy.

This description comes directly from the study's public registry record.

Talk to the study team

AstraZeneca Clinical Study Information Center  ·  1-877-240-9479  ·  information.center@astrazeneca.com

Always discuss trial participation with your own doctor first.

Locations (36)

Research SiteAnhui, ChinaRecruiting
Research SiteAnning, ChinaRecruiting
Research SiteBeijing, ChinaRecruiting
Research SiteBinzhou, ChinaRecruiting
Research SiteChangzhou, ChinaRecruiting
Research SiteFenyang, ChinaRecruiting
Research SiteGuangdong, ChinaRecruiting
Research SiteGuangzhou, ChinaRecruiting
Research SiteHangzhou, ChinaRecruiting
Research SiteHuzhou, ChinaRecruiting
Research SiteJiaxing, ChinaRecruiting
Research SiteJinan, ChinaRecruiting

+ 24 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06862206